ENDRA Life Sciences Inc. $NDRA

By Microcap Ledger desk · CIK 0001681682

Facts as of Oct 11, 2026, 08:17 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange: Nasdaq Capital Market
Sector: Electromedical & Electrotherapeutic Apparatus
Headquarters: Ann Arbor, MI
Fiscal year end: December 31
Shares outstanding: 1,499,838 [10-Q 2026-08-14]
as of 2026-08-14

Sources: [10-K 2026-03-31]

What the company doesAI summary of filing

ENDRA Life Sciences Inc. develops TAEUS (Thermo-Acoustic Ultrasound) applications, which are medical devices undergoing regulatory approval. The company is currently pre-revenue and clinical-stage, with its MASLD TAEUS device under FDA review via a de novo process and its FLIP system having received CE mark approval in Europe as of March 2020. ENDRA manufactures through original equipment manufacturers (OEMs) and generates revenue primarily through regulatory approvals and commercialization of TAEUS technology, though it also holds cryptocurrency as part of its treasury strategy. The company faces significant regulatory, clinical trial, and intellectual property challenges typical of early-stage medical device developers. [10-K 2026-03-31]

Segments: TAEUS MASLD device, TAEUS FLIP system, Digital asset treasury

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	—	−$1.15M	−$2.05M	$1.74M	[S-4 2026-10-02]
FY ended Dec 2025	—	−$7.03M	−$5.18M	$762.4K	[S-4 2026-10-02]
FY ended Dec 2024	—	−$11.51M	−$7.40M	$3.23M	[S-4 2026-10-02]

Quarterly cash burn: −$1.02M
Cash runway Estimate: ~5.1 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2024-11-19	536,908	[10-Q/A 2024-11-21]
2025-03-24	562,213	[10-K/A 2025-04-07]
2025-05-15	738,370	[10-Q 2025-05-15]
2025-08-14	752,755	[10-Q 2025-08-14]
2025-11-14	1,166,441	[10-Q 2025-11-14]
2026-03-31	1,240,751	[10-K 2026-03-31]
2026-05-15	1,270,077	[10-Q 2026-05-15]
2026-08-14	1,499,838	[10-Q 2026-08-14]

Shelf registration: S-3 filed 2025-11-06; no effectiveness notice found in EDGAR [S-3 2025-11-06]

Listing status

Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-21. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2026-04-21	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2026-04-21]
2025-05-30	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-05-30]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
Date	Insider	Type	Shares	Price	Filing
2026-03-02	Tokman Alexander Y	grant	26,921	—	[4 2026-03-04]
2026-03-02	Jacroux Richard	grant	13,461	—	[4 2026-03-04]
2026-01-21	Digiandomenico Anthony	grant	60,324	—	[4 2026-01-23]
2026-01-21	Harsh Michael	grant	60,324	—	[4 2026-01-23]
2026-01-21	Jacroux Richard	grant	20,000	—	[4 2026-01-23]
2026-01-21	Basenese Lou	grant	60,324	—	[4 2026-01-23]
2026-01-21	Tokman Alexander Y	grant	75,000	—	[4 2026-01-23]
2025-10-10	Digiandomenico Anthony	grant	70,822	$7.06	[4 2025-10-15]

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-10-08	13D	Beneficial ownership report (5%+ holder)
2026-10-01	8-K	Material agreement entered
2026-08-17	8-K	Results of operations
2026-08-14	10-Q	Quarterly report
2026-07-09	8-K	Other events
2026-06-29	13D/A	Beneficial ownership report (5%+ holder)
2026-06-26	8-K	Material agreement entered; Change in control; Regulation FD disclosure
2026-06-25	8-K	Regulation FD disclosure
2026-05-28	8-K	Material agreement entered; Unregistered sale of equity; Other events
2026-05-15	10-Q	Quarterly report
2026-04-21	8-K	Listing notice or transfer
2026-03-31	10-K	Annual report

Facts as of Oct 11, 2026, 08:17 AM UTC. Small caps move fast; check the latest filings.